GM Advisory Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,693
| Closed | -$214K | – | 380 |
|
|
2025
Q4 | $214K | Buy |
+2,693
| New | +$212K | 0.01% | 322 |
|
|
2025
Q1 | – | Sell |
-5,265
| Closed | -$236K | – | 273 |
|
|
2024
Q4 | $236K | Sell |
5,265
-1,984
| -27% | -$111K | 0.01% | 234 |
|
|
2024
Q3 | $456K | Sell |
7,249
-3,834
| -35% | -$224K | 0.03% | 170 |
|
|
2024
Q2 | $655K | Sell |
11,083
-154
| -1% | -$9.63K | 0.04% | 138 |
|
|
2024
Q1 | $896K | Buy |
11,237
+551
| +5% | +$42.1K | 0.06% | 118 |
|
|
2023
Q4 | $844K | Buy |
10,686
+2,374
| +29% | +$169K | 0.06% | 107 |
|
|
2023
Q3 | $580K | Sell |
8,312
-975
| -10% | -$69.1K | 0.05% | 112 |
|
|
2023
Q2 | $642K | Buy |
9,287
+351
| +4% | +$25K | 0.05% | 105 |
|
|
2023
Q1 | $664K | Buy |
8,936
+916
| +11% | +$76.8K | 0.06% | 101 |
|
|
2022
Q4 | $747K | Buy |
8,020
+357
| +5% | +$34.4K | 0.08% | 89 |
|
|
2022
Q3 | $731K | Sell |
7,663
-100
| -1% | -$9.9K | 0.09% | 81 |
|
|
2022
Q2 | $719K | Sell |
7,763
-360
| -4% | -$35.1K | 0.11% | 89 |
|
|
2022
Q1 | $822K | Sell |
8,123
-6,108
| -43% | -$642K | 0.1% | 97 |
|
|
2021
Q4 | $1.47M | Hold |
14,231
| – | – | 0.13% | 79 |
|
|
2021
Q3 | $1.21M | Sell |
14,231
-360
| -2% | -$30.2K | 0.12% | 84 |
|
|
2021
Q2 | $1.22M | Sell |
14,591
-602
| -4% | -$49.3K | 0.12% | 82 |
|
|
2021
Q1 | $1.14M | Sell |
15,193
-8,138
| -35% | -$593K | 0.14% | 75 |
|
|
2020
Q4 | $1.59M | Sell |
23,331
-17,051
| -42% | -$1.11M | 0.21% | 55 |
|
|
2020
Q3 | $2.36M | Buy |
40,382
+1,218
| +3% | +$75.8K | 0.36% | 39 |
|
|
2020
Q2 | $2.54M | Sell |
39,164
-3,751
| -9% | -$236K | 0.47% | 34 |
|
|
2020
Q1 | $2.55M | Buy |
+42,915
| New | +$2.86M | 0.69% | 23 |
|
|
2019
Q4 | – | Sell |
-4,036
| Closed | -$255K | – | 102 |
|
|
2019
Q3 | $255K | Hold |
4,036
| – | – | 0.08% | 87 |
|
|
2019
Q2 | $220K | Buy |
+4,036
| New | +$217K | 0.07% | 102 |
|
|
2018
Q4 | – | Sell |
-3,011
| Closed | -$237K | – | 107 |
|
|
2018
Q3 | $237K | Buy |
+3,011
| New | +$215K | 0.07% | 95 |
|
|
2018
Q1 | – | Sell |
-3,068
| Closed | -$222K | – | 128 |
|
|
2017
Q4 | $222K | Buy |
+3,068
| New | +$223K | 0.06% | 115 |
|
Other funds holding CVS
VCM
VPM
GM Advisory Group's CVS Position: Q1 2026 in Review
GM Advisory Group sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,693 shares — an estimated $214K sold.
GM Advisory Group first reported a position in CVS in Q4 2017 and held it in 25 quarters. The position peaked at $2.55M in Q1 2020. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- GM Advisory Group reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- GM Advisory Group sold 2,693 CVS Health shares in Q1 2026, an estimated $214K.
- GM Advisory Group first reported a position in CVS Health in Q4 2017 and held it in 25 quarters.
- GM Advisory Group's CVS Health position peaked at $2.55M in Q1 2020.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.